S855P
Category 5 — IDR ExclusionConflictingLumenal · predictedσ-1 candidateEditorialSer→Pro p855 lumenal AM=0.09 ddg=-0.08 pLDDT=45. ClinVar Conflicting evidence. Atlas mechanism: see structural analysis.
Interactive 3D Structure
Bond changes · DynaMut2 interaction analysis
| Interaction type | Wild-type partner | Mutant partner | Status |
|---|---|---|---|
| Hydrogen bond | — | Q853 | Gained |
| Hydrogen bond | T857 | T857 | Preserved |
| Polar contact | — | Q853 | Gained |
| Polar contact | T857 | T857 | Preserved |
Lost / gained / preserved interatomic contacts at the variant residue, from the DynaMut2 (Arpeggio) interaction analysis of the wild-type and energy-minimized mutant structures.
Computational Predictions
Clinical Evidence
Not observed in ~730k individuals — consistent with a rare allele (ACMG PM2_supporting).
Structural Context
Position analysis: LEU854 (2.5 Å), PRO856 (2.5 Å — adjacent existing P! Pro-Pro motif!), THR857 (4.1 Å). Pro-Pro motif created at 855-856. pLDDT 45 IDR boundary. The Atlas's neighbor extraction surfaces this variant's contacts.
Druggability Assessment
Why this matters
Feed this card to Wolfram Intelligence
Download the S855P PDF below and upload it to Wolfram Intelligence to generate therapeutic-strategy proposals — guanidinium mimetics, sigma-1 agonist docking, NAC thiol-capping. NAC is already on the bench-testing list.